These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 26615886

  • 1. Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent.
    Zhang L, Chen F, Zhang Z, Chen Y, Wang J.
    Bioorg Med Chem Lett; 2016 Jan 01; 26(1):38-42. PubMed ID: 26615886
    [Abstract] [Full Text] [Related]

  • 2. Aromatic heterocyclic esters of podophyllotoxin exert anti-MDR activity in human leukemia K562/ADR cells via ROS/MAPK signaling pathways.
    Zhang L, Zhang Z, Chen F, Chen Y, Lin Y, Wang J.
    Eur J Med Chem; 2016 Nov 10; 123():226-235. PubMed ID: 27484511
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and anticancer activity of dichloroplatinum(II) complexes of podophyllotoxin.
    Liu X, Zhang LL, Xu XH, Hui L, Zhang JB, Chen SW.
    Bioorg Med Chem Lett; 2013 Jul 01; 23(13):3780-4. PubMed ID: 23711918
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
    Cheng WH, Cao B, Shang H, Niu C, Zhang LM, Zhang ZH, Tian DL, Zhang S, Chen H, Zou ZM.
    Eur J Med Chem; 2014 Oct 06; 85():498-507. PubMed ID: 25113878
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of novel podophyllotoxin-NSAIDs conjugates as multifunctional anti-MDR agents against resistant human hepatocellular carcinoma Bel-7402/5-FU cells.
    Zhang L, Liu L, Zheng C, Wang Y, Nie X, Shi D, Chen Y, Wei G, Wang J.
    Eur J Med Chem; 2017 May 05; 131():81-91. PubMed ID: 28301815
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells.
    Guo YE, Chen H, Zuo S, Liu DL, Lu YL, Lv JJ, Wen SP, Zhang TC.
    J Asian Nat Prod Res; 2011 May 05; 13(5):417-24. PubMed ID: 21534039
    [Abstract] [Full Text] [Related]

  • 7. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
    Zhou H, Lv S, Zhang D, Deng M, Zhang X, Tang Z, Chen X.
    Acta Biomater; 2018 Jun 05; 73():388-399. PubMed ID: 29694920
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. One-pot synthesis and biological evaluation of N-(aminosulfonyl)-4-podophyllotoxin carbamates as potential anticancer agents.
    Xu XH, Guan XW, Feng SL, Ma YZ, Chen SW, Hui L.
    Bioorg Med Chem Lett; 2017 Jul 01; 27(13):2890-2894. PubMed ID: 28512026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Investigation of podophyllotoxin esters as potential anticancer agents: synthesis, biological studies and tubulin inhibition properties.
    Shareef MA, Duscharla D, Ramasatyaveni G, Dhoke NR, Das A, Ummanni R, Srivastava AK.
    Eur J Med Chem; 2015 Jan 07; 89():128-37. PubMed ID: 25462233
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and anti-cancer activity evaluation of podophyllotoxin-norcantharidin hybrid drugs.
    Han HW, Qiu HY, Hu C, Sun WX, Yang RW, Qi JL, Wang XM, Lu GH, Yang YH.
    Bioorg Med Chem Lett; 2016 Jul 15; 26(14):3237-3242. PubMed ID: 27262599
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis and antineoplastic activity of novel hybrids of podophyllotoxin and indirubin against human leukaemia cancer cells as multifunctional anti-MDR agents.
    Wang J, Long L, Chen Y, Xu Y, Zhang L.
    Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1817-1824. PubMed ID: 29678463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.